Send E-mail
  • Celltrion signs W135b contract with affiliate for Remsima
    Celltrion signs W135b contract with affiliate for Remsima
    Celltrion (068270) announced on Sept. 20 that it has signed a 134.9 billion won (US$120.40 million) contract with its affiliate Celltrion Healthcare to provide biosimilar antibody Remsima. This amounts to 22.36 percent of its revenue last year and the contract expires on Sept. 30.(theinvestor@heraldcorp.com)
From
Send to
Close Send

Celltrion signs W135b contract with affiliate for Remsima

Sept. 20, 2016 - 17:47 By 황유미
[DISCLOSURE] Celltrion (068270) announced on Sept. 20 that it has signed a 134.9 billion won (US$120.40 million) contract with its affiliate Celltrion Healthcare to provide biosimilar antibody Remsima. 

This amounts to 22.36 percent of its revenue last year and the contract expires on Sept. 30.

(theinvestor@heraldcorp.com)
Most Popular